Details of Drug-Drug Interaction
| Drug General Information (ID: DDI5T8JEU0) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Miglitol | Drug Info | Activated charcoal | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Antidiabetic Agents | Antidotes | |||||||
| Structure | |||||||||
| Mechanism of Miglitol-Activated charcoal Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Adsorption Click to Show/Hide Mechanism Graph | |||||||||
![]() |
|||||||||
| Drug Name | Miglitol | Activated charcoal | |||||||
| Mechanism | Adsorbed by activated charcoal | Activated charcoal | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Adsorption | ||||||||
| Factor Description | Adsorption is a direct drug interaction, usually through adsorption on its surface, resulting in reduced absorption of concomitantly administered drugs in the gastrointestinal tract. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Alpha-glucosidase inhibitors should not be administered simultaneously with intestinal adsorbents or preparations containing carbohydrate-splitting digestive enzymes. The optimal dosing interval between these agents has not been established. Postprandial blood glucose and glycosylated hemoglobin (HbA1c) should be monitored to ensure adequate therapeutic response to alpha-glucosidase inhibitor therapy. | ||||||||
| References | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Product Information. Glyset (miglitol). Bayer, West Haven, CT. | ||||||||||||||||||
| 2 | Product Information. Precose (acarbose). Bayer, West Haven, CT. | ||||||||||||||||||

